Thioridazine

Thioridazine is a type of medicine called an antipsychotic. It's used to help manage certain mental health conditions like schizophrenia. It works by affecting chemicals in the brain.

Brand names:Mellaril
Medication

What people taking Thioridazine report

Every report comes from a Lived member, sent anonymously.

Have you tried Thioridazine for Schizophrenia?

NameHow it went

About Thioridazine

What It's For

Thioridazine is an older antipsychotic medicine used to treat schizophrenia, a long-term mental illness that affects how a person thinks, feels and makes sense of reality. It was once sold under the brand name Mellaril, which is no longer on the US market; today it is available as generic tablets. Because thioridazine can cause a dangerous heart rhythm problem, it is not a first-choice treatment. In the US it is approved only for people whose schizophrenia has not improved enough with other antipsychotics, or who could not reach an effective dose of them because of side effects, and its label recommends trying at least two different antipsychotics first. In older studies it worked about as well as other antipsychotics of its generation. It has not been tested in controlled trials specifically in people whose illness resisted other treatment, so how much it helps that group is not known. It is not approved for psychosis or behavior problems linked to dementia.

How It Works

Thioridazine belongs to the phenothiazine family of first-generation, or typical, antipsychotics. These medicines block receptors for dopamine, a chemical messenger in the brain. Dampening dopamine signaling is believed to be how they ease psychotic symptoms such as hallucinations and delusions (firmly held false beliefs), although it does not fully explain why some people respond well and others do not. Compared with many older antipsychotics, thioridazine tends to cause fewer movement-related side effects such as stiffness and tremor. The trade-off is that it slows the electrical resetting of the heart between beats. On an electrocardiogram (ECG), this shows up as a longer QTc interval. The effect grows with the dose, and it is the reason the medicine's use is restricted.

Dosage & Administration

Thioridazine comes as tablets taken by mouth, usually two to four times a day at around the same times each day. The prescriber starts with a lower dose, raises it gradually until symptoms are controlled, and then tries to lower it to the smallest dose that keeps symptoms in check. For adults, the label's total daily range is 200 to 800 mg, and 800 mg a day is the maximum. Children whose schizophrenia has not responded to other medicines are dosed by body weight. Staying within the prescribed dose matters, because both the heart rhythm risk and a rare eye problem become more likely at higher doses. Before the first dose, the care team checks an ECG and a blood potassium level. The QTc interval on the ECG, measured in milliseconds, reflects how long the heart's lower chambers take to recover after each beat. Under the label, thioridazine should not be started if the QTc is above 450 milliseconds, and it should be stopped if the QTc rises above 500. Low potassium also makes rhythm problems more likely, so it is corrected before treatment begins. Repeat ECGs and potassium checks may be done during treatment, especially after a dose change. If a dose is missed, take it when remembered unless the next dose is nearly due, and do not take two doses together. Do not stop taking thioridazine without a plan from the prescriber.

Side Effects

Drowsiness is common, especially early in treatment or after a dose increase, and often eases with time or a lower dose. Dry mouth, blurred vision, constipation, nausea, a stuffy nose and weight gain can also occur. Some people feel dizzy or lightheaded when standing up quickly because their blood pressure drops; together with drowsiness, this raises the risk of falls. Getting up slowly, sitting on the edge of the bed for a few minutes before standing, can help, and lightheadedness on standing that keeps happening is worth mentioning to the prescriber. Hormone-related effects can include breast enlargement or milk production, missed periods and problems with ejaculation or erections. The most serious risk is torsades de pointes, a fast, chaotic heart rhythm that can cause fainting or sudden death. Thioridazine carries the strongest (boxed) warning from the US Food and Drug Administration (FDA) for this. Call the prescriber immediately for a fast, pounding or irregular heartbeat, for dizziness or lightheadedness that comes with a racing or uneven heartbeat or comes on while sitting or lying down, or for fainting. A few uncommon reactions also need prompt attention. Neuroleptic malignant syndrome is a rare, potentially fatal reaction to antipsychotics; high fever with stiff muscles, confusion, sweating or a racing pulse needs urgent medical assessment. Tardive dyskinesia causes repetitive movements a person cannot control, often of the tongue, lips, face or jaw. It can become permanent, its risk rises with longer use and higher total doses, and it is most common in older adults, especially women, so new movements should be reported early. Changes in vision, especially worse night vision or a brownish tint, can signal pigment damage in the retina, seen mainly at doses above the recommended range. Fever, sore throat or other signs of infection can rarely reflect a drop in white blood cells. An erection that lasts for hours also needs an immediate call to the prescriber, or emergency care if the prescriber cannot be reached right away.

Interactions & Warnings

Many medicines can add to thioridazine's heart rhythm risk, and its label rules out several combinations. It must not be taken with other drugs that lengthen the QTc interval. The liver clears thioridazine mainly through an enzyme called CYP2D6, so medicines that block this enzyme push thioridazine levels up; the antidepressants fluoxetine and paroxetine are examples. Fluvoxamine (an antidepressant often used for obsessive-compulsive disorder) and the beta blockers propranolol and pindolol (used for blood pressure, heart and other conditions) also raise its levels and should not be combined with it. About 7% of people inherit low CYP2D6 activity, and thioridazine should not be used by anyone known to have it, for example from a genetic test. Because the list of risky combinations is long, tell every prescriber and pharmacist that you take thioridazine before starting any new medicine. Thioridazine should also not be used by people with congenital long QT syndrome (an inherited heart rhythm condition), a history of heart rhythm problems, or severely reduced alertness or consciousness from any cause. A slow heart rate and low potassium add to the risk. It strengthens the effects of alcohol, opioids, sedatives and other drugs that cause drowsiness, so tell the surgical or dental team before any procedure, and ask the prescriber about alcohol. Older adults with dementia who take antipsychotics have a higher risk of death, mostly from heart problems or infections such as pneumonia, and thioridazine is not approved for that use. Older adults generally should not take it, because other options for schizophrenia are safer. Babies exposed in the last three months of pregnancy can have stiffness, tremor, sleepiness, or breathing or feeding problems after birth, sometimes needing intensive care. Anyone pregnant or planning pregnancy should weigh the benefits and risks with the prescriber rather than stopping on their own. Thioridazine can also cause false positive home pregnancy tests. Thioridazine is especially dangerous in overdose because of its effects on the heart. If someone has taken too much and has collapsed, had a seizure, has trouble breathing or cannot be woken, call 911.

What to Expect

Starting thioridazine involves a conversation about why other antipsychotics were not suitable, followed by an ECG and blood tests. Doses are raised gradually, and drowsiness and dizziness on standing tend to be most noticeable in the early weeks. How quickly symptoms improve varies from person to person, so response is reviewed at follow-up visits. Thioridazine can help control the symptoms of schizophrenia, but it does not cure the illness. Many people need long-term treatment, and stopping can allow symptoms to return, so it is usually continued even when someone feels well, with any change made together with the prescriber. Over time, the prescriber aims for the lowest dose that works, periodically reassesses whether it is still needed, and watches for tardive dyskinesia. Ongoing care can include repeat ECGs and potassium checks, blood counts for people who have had low white blood cell counts before, and a check of every new medicine.

Questions to Ask Your Doctor

  1. 1.Which antipsychotics have I already tried, and why is thioridazine the right next step rather than another option such as clozapine, the antipsychotic most often used when schizophrenia has not responded to other medicines?
  2. 2.What did my ECG and potassium results show, and how often will they be rechecked?
  3. 3.Do any of my current medicines, including antidepressants or beta blockers, interact with thioridazine?
  4. 4.How will we judge whether it is working, and what would we try if it is not?
  5. 5.What should I do if I notice an irregular heartbeat, fainting or new uncontrollable movements?

Last reviewed • Oct 2026

Educational content, not medical advice.